VANGUARD GROUP INC - IMMUNOMEDICS INC ownership

IMMUNOMEDICS INC's ticker is IMMU and the CUSIP is 452907108. A total of 418 filers reported holding IMMUNOMEDICS INC in Q3 2020. The put-call ratio across all filers is 0.82 and the average weighting 1.3%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of IMMUNOMEDICS INC
ValueSharesWeighting
Q3 2020$1,539,836,000
+130.3%
18,109,323
-4.0%
0.05%
+112.5%
Q2 2020$668,546,000
+194.3%
18,864,135
+12.0%
0.02%
+140.0%
Q1 2020$227,135,000
-34.1%
16,849,782
+3.5%
0.01%
-16.7%
Q4 2019$344,564,000
+71.3%
16,283,773
+7.3%
0.01%
+71.4%
Q3 2019$201,139,000
-4.3%
15,168,878
+0.1%
0.01%
-12.5%
Q2 2019$210,161,000
-26.1%
15,152,261
+2.3%
0.01%
-27.3%
Q1 2019$284,540,000
+36.6%
14,812,105
+1.4%
0.01%
+22.2%
Q4 2018$208,352,000
-29.3%
14,600,685
+3.2%
0.01%
-25.0%
Q3 2018$294,675,000
-12.2%
14,146,605
-0.2%
0.01%
-14.3%
Q2 2018$335,440,000
+168.0%
14,171,524
+65.4%
0.01%
+180.0%
Q1 2018$125,152,000
+43.9%
8,566,235
+59.1%
0.01%
+25.0%
Q4 2017$86,985,000
+33.3%
5,382,730
+15.3%
0.00%
+33.3%
Q3 2017$65,274,000
+63.5%
4,669,110
+3.3%
0.00%
+50.0%
Q2 2017$39,930,000
+39.7%
4,522,091
+2.4%
0.00%
+100.0%
Q1 2017$28,574,000
+97.2%
4,416,533
+11.9%
0.00%0.0%
Q4 2016$14,490,000
+18.8%
3,948,219
+5.2%
0.00%0.0%
Q3 2016$12,197,000
+42.9%
3,752,828
+2.0%
0.00%0.0%
Q2 2016$8,533,000
-5.4%
3,677,769
+1.9%
0.00%0.0%
Q1 2016$9,020,000
-14.6%
3,607,879
+4.8%
0.00%0.0%
Q4 2015$10,565,000
-94.8%
3,441,605
-73.4%
0.00%
-87.5%
Q3 2015$204,472,000
+1469.2%
12,934,549
+303.0%
0.01%
+700.0%
Q2 2015$13,030,000
+8.8%
3,209,544
+2.7%
0.00%0.0%
Q1 2015$11,974,000
-28.2%
3,126,554
-10.0%
0.00%0.0%
Q4 2014$16,682,000
+49.2%
3,475,447
+15.7%
0.00%0.0%
Q3 2014$11,178,000
+5.9%
3,004,656
+3.9%
0.00%0.0%
Q2 2014$10,554,000
-8.2%
2,891,306
+5.9%
0.00%0.0%
Q1 2014$11,493,000
-2.4%
2,729,864
+6.6%
0.00%0.0%
Q4 2013$11,776,000
-23.2%
2,560,093
+3.3%
0.00%0.0%
Q3 2013$15,337,000
+11.8%
2,477,809
-1.7%
0.00%0.0%
Q2 2013$13,717,0002,521,4470.00%
Other shareholders

There were no reported owners of IMMUNOMEDICS INC in Q3 2020.

NameSharesValueWeighting ↓
View complete list of IMMUNOMEDICS INC shareholders